Active range of motion of the ankle joint · children with ITW gait
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change from baseline in passive ankle dorsiflexion range of movement · children with ITW gait
1 finding from 1 review
Pain · children with ITW gait
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence of ITW post‐treatment Assessed by improvement in toe walking based on Gait Analysis Classification An increase indicates improvement (an improvement indicated by a change in downgrading of the severe or 3, moderate or 2, and mild or 1 c... · children with ITW gait
1 finding from 1 review
Adverse events · children with ITW gait
It is very uncertain whether botulinum toxin plus conservative treatment changes adverse events compared with conservative treatment only (very low certainty).
1 finding from 1 review
Sensory functions and pain · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neuromusculoskeletal and movement‐related functions at 12 weeks (measured by ankle dorsiflexion) · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
1 finding from 1 review
General tasks and demands · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mobility · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Self‐care · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Spasticity at 4‐12 weeks (measured by both Modified Ashworth Scale, 0‐5, at 12 weeks and Tardieu Scale, 0‐5, at 4 weeks) · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
1 finding from 1 review
Adverse events · adults with traumatic brain injury with spasticity in their arms (1 study) or calves (1 study)
1 finding from 1 review
Overall cervical dystonia improvement as · adults with cervical dystonia
1 finding from 1 review
Withdrawals due to adverse events · adults with cervical dystonia
Botulinum neurotoxin B showed no clear difference in proportion of withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Cervical dystonia‐specific pain · adults with cervical dystonia
1 finding from 1 review
Subjective change as assessed by the patient at week 4 · adults with cervical dystonia
1 finding from 1 review
Proportion of participants with adverse events · adults with cervical dystonia
It is very uncertain whether botulinum neurotoxin B changes proportion of participants with adverse events compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: dry mouth · adults with cervical dystonia
Botulinum neurotoxin B leads to higher adverse events: dry mouth compared with placebo (high certainty).
1 finding from 1 review
Dysphagia · adults with cervical dystonia
Botulinum neurotoxin B leads to higher adverse events: dysphagia compared with placebo (high certainty).
1 finding from 1 review
Partcipant assessment of success · glabellar lines
Summary of Findings Table ‐ OnabotulinumtoxinA 20U probably leads to higher partcipant assessment of success compared with placebo (moderate certainty).
1 finding from 1 review